Pfizer COVID 19 Pill Secures FDA Approval

• The U.S Food and Drug Administration Pfizer’s Covid 19 pill as the first oral antiviral pill

• The pill is recommended for people at a high risk of developing severe symptoms

• The FDA and CDC have given the go-ahead for the pill to be administered from this weekend

The U.S Food and Drug Administration has given the approval for Pfizer’s Covid 19 pill to be used in the country as early as this weekend.

The authorization of the covid pill has been regarded as a major milestone in the revolution of the virus.

The oral antiviral pill is recommended for people at high risk of severe symptoms of the disease.

The Centers for Disease Control and Prevention is expected to approve distribution as Pfizer has already shipped some of the pills to the U.S.

At the moment, the pill has only been endorsed to be used on patients who are 12 and above and are likely to be hospitalized or not survive from the symptoms of the disease.

Read also: Elon Musk Argues that Neuralink is Better than the Metaverse

Speaking after the authorization of the pill, the Director of the FDA’s Center for Drug Evaluation and Research, Dr. Patrizia Cavazonni said:

“Today’s authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally — a major step forward in the fight against this global pandemic. This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19.”

The company has said that it is ready to start delivery in the U.S and a deal has been secured with the U.S for the sale of 10 million courses of the Paxlovid COVID 19 pill.

Follow Naija.fm on our social media handles Facebook, Instagram, and Twitter to keep up with trending news, breaking news, entertainment news, and hot gist.